Navigating the Future: Growth Trajectory and Innovations in Optical Genome Mapping
Optical Genome Mapping Market |
The global optical genome mapping market is expected to exhibit significant growth over the forecast period owing to the various advantages of optical genome mapping such as its ability to identify structural variations at a much higher resolution as compared to other genome mapping technologies. Optical genome mapping finds wide applications in various areas including diagnostics of genetic disorders, cancer research, personalized medicine, agriculture, and livestock improvement. It helps identify complex genome rearrangements that are difficult to detect using other conventional techniques.
The Global optical genome mapping market is estimated to be valued at US$ 109.9 million in 2024 and is
expected to exhibit a CAGR of 21%
over the forecast period 2024 to 2031. Increasing investments in genome mapping
projects and growing focus on genome analysis are some of the key factors
driving the growth of this market.
Key Takeaways
Key players operating in the optical genome mapping market are Bionano
Genomics, Nucleome Informatics Private Limited, Praxis Genomics, LLC, SourceBio
International Limited (Source BioScience), MedGenome, INRAE (French Plant
Genomic Resources Center (CNRGV)), PerkinElmer (PerkinElmer Genomics), Genohub
Inc., Hofkens Lab, and Cerba.
The demand for Optical
Genome Mapping Market is increasing primarily due to its rising
applications in prenatal diagnosis, cancer research, and agricultural research.
Optical genome mapping helps identify complex structural variants associated
with diseases and developmental disorders, therefore finding increased usage in
clinical diagnostics.
Technological advancements are further expanding the potential applications of
optical genome mapping. Companies are focused on developing algorithms and
software for efficient data analysis from optical genome mapping. Advancements
in hardware and consumables are also improving mapping throughput and
resolution.
Market Trends
Growing adoption of optical genome mapping for cancer research: Optical genome
mapping is gaining popularity for detecting translocations, inversions, and
complex genomic rearrangements associated with various types of cancers. It is
being increasingly used along with next-generation sequencing for comprehensive
cancer genome analysis.
Increasing usage in crop improvement programs: Organizations involved in crop
research and improvement are utilizing optical genome mapping for trait
mapping, marker development, and detection of structural variations in plant
genomes. This is helping accelerate the development of new crop varieties.
Market Opportunities
Combined use with other omics technologies: Integrating optical genome
mapping data with transcriptomics, epigenomics and proteomics datasets offers
opportunities for comprehensive multi-omics analysis. This can provide novel
insights into disease mechanisms and pathways.
Expansion in genetic disorder diagnostics: With continued technological
improvements, optical genome mapping can be used for efficient diagnosis of a
wider range of genetic disorders, especially those caused by complex structural
variants, thereby improving patient outcomes.
Impact of Covid-19 on Global Optical
Genome Mapping Market
The COVID-19 pandemic has negatively impacted the growth of the global optical
genome mapping market. During the initial stages of the pandemic, hospitals and
healthcare facilities shifted their focus and resources towards managing
COVID-19 patients. This resulted in cancellation or deferment of elective
medical procedures including genome mapping procedures. Supply chain
disruptions and restrictions on international trade further constrained the
availability of key instruments and reagents required for optical genome
mapping.
Post
pandemic recovery, the demand for genome mapping is expected to rise
significantly. With increasing research on identifying genetic markers
associated with increased susceptibility to severe COVID-19 infections, genome
mapping tools like optical mapping are being extensively utilized. Various
studies are investigating if certain inherited genetic variants are linked to
worse outcomes from SARS-CoV-2. Genome mapping helps in decoding complex
structural variations which traditional sequencing may miss. It can provide
clinically actionable insights and help develop more effective therapeutics and
vaccines. To combat future pandemics, governments and private sector are
increasing investments in genomic research infrastructure including optical
mapping systems.
Geographical Regions with High Concentration in Global Optical Genome Mapping
Market
In terms of value, North America holds the major share of the global optical
genome mapping market currently. This is attributed to the presence of key
market players and established healthcare infrastructure and research funding
in the region. The United States alone accounts for over half of the global market
currently supported by large genome mapping initiatives by NIH and other
foundations. Asia Pacific is expected to be the fastest growing region during
the forecast period led by China, Japan and India. Favorable government
policies supporting genomic research and increasing healthcare investments are
driving higher adoption of advanced technologies like optical genome mapping in
the Asia Pacific region. Europe is another major geographical region within the
global optical genome mapping market supported by increasing translational
research activities and availability of reimbursements for genomic tests.
Fastest Growing Region in Global Optical
Genome Mapping Market
Asia Pacific region is poised to be the fastest growing region in the
global optical genome mapping market during the forecast period. This is
attributed to rising healthcare expenditures, increasing awareness about
genetic disorders and personalized medicine, large cancer disease burden as
well as growing collaborations between regional and international market
players. China and India with their huge population base and unmet medical
needs represent lucrative growth opportunities. Favourable regulatory
environment supporting clinical adoption of genomic technologies further boosts
the adoption of optical genome mapping systems in the region. Expanding network
of genome sequencing centers and initiatives such as 100,000 Genomes Project in
China and Genomic England Project are positively impacting the Asia Pacific
optical genome mapping market.
Get
more insights on Optical
Genome Mapping Market
Comments
Post a Comment